$35.50-8.29% · 3M
Moving avg
1W-3.19%
1M-12.52%
3M-8.29%
6M-21.18%
YTD-12.60%
1Y-13.41%
3Y-13.41%
5Y-13.41%
52-week range
$32.8215% of range$50.88
Company health
Value3/6
Growth5/6
Profitability3/6
Health2/6
Dividend1/6
Bull vs bear
Strengths
- Analysts see 44% upside to a $51 target
- Analyst consensus is "Buy"
- High return on equity (687%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$30.02B
Enterprise value
$44.17B
P/E ratio (TTM)
33.00x
P/S ratio (TTM)
1.16x
EV/EBITDA
16.17x
Per share & returns
EPS (TTM)
$1.18
Dividend yield
0.00%
Beta (1Y)
-0.42
30-day change
-12.52%
Trading
Volume (24h)
6.63M
Previous close
$35.04
Shares outstanding
845.61M
About Medline Inc.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ
Symbol
MDLN
Medline Inc. is a large-cap healthcare company in the Medical - Instruments & Supplies industry. Its shares are listed on NASDAQ (United States) and trade under the ticker MDLN.
Frequently asked questions
What is Medline Inc.'s market cap?
Medline Inc. (MDLN) has a market capitalization of $30.02B.
What is Medline Inc.'s P/E ratio?
Medline Inc. trades at a price-to-earnings (P/E) ratio of 33.00.
What exchange does MDLN trade on?
MDLN trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.92B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.41B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap